Cyclosporine trials in diabetes: updated results of the French experience.
Assan
R
R
Service de Diabétologie, Hôpital Bichat, Paris, France.
Feutren
G
G
Sirmai
J
J
D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D002096:C-Peptide / Q000097:blood; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence
D002096:C-Peptide; D003524:Cyclosporins; D007328:Insulin; D001379:Azathioprine; D011241:Prednisone